Skip to content

15 min reading time

Preventing SIBO relapse: Address the root causes

Preventing SIBO relapse: Address the root causes

Small intestinal bacterial overgrowth happens when excessive numbers of bacteria accumulate in the small intestine. In a healthy body, the small intestine contains very few bacteria. The body uses several mechanical, chemical, and immune defense systems to maintain this balance and prevent bacteria from multiplying in the wrong location1. When these physical and chemical defenses fail, bacteria take over the small intestine and cause digestive distress.
Clearing the bacteria with antimicrobial therapy is only the first step in addressing this condition. Up to 44 percent of people experience a return of their symptoms within nine months of their initial treatment3. This high relapse rate occurs because the original conditions that allowed the bacteria to grow remain active4. Eradicating the bacteria does not fix a broken digestive system. Preventing a recurrence requires identifying and managing the underlying bodily failures that created a hospitable environment for the bacteria in the first place.

The migrating motor complex and digestive movement

The most common reason for a relapse is poor movement within the digestive tract. The body uses a mechanical sweeping action to keep the small intestine clean. This physiological process is called the migrating motor complex. It is a series of wave-like muscle contractions that push leftover food, waste, and bacteria out of the small intestine and into the large intestine2.
The migrating motor complex acts as an internal cleaning system. It only operates when the digestive tract is empty. Phase III of this complex is the most active phase, creating strong contractions that sweep through the gut6. This process typically starts about two to three hours after a meal and repeats every 90 minutes as long as the person continues to fast7. When this cleaning wave is weak, delayed, or completely absent, bacteria linger in the small intestine, feed on remaining food particles, and multiply rapidly4. Addressing the reasons behind a broken migrating motor complex is the primary focus of preventing a relapse.

Food poisoning and nerve damage

A major disruptor of the migrating motor complex is a history of food poisoning or acute gastroenteritis. Infections from common foodborne bacteria like Escherichia coli, Salmonella, Shigella, or Campylobacter cause long-term damage to the nerves of the digestive tract9. This condition is known as post-infectious irritable bowel syndrome.
These infectious bacteria release a specific toxin called cytolethal distending toxin B9. When the body detects this toxin, the immune system creates antibodies to hunt it down and destroy it. A biological mix-up often occurs during this immune response. The structure of cytolethal distending toxin B looks very similar to vinculin, a natural protein found in the human digestive tract. Vinculin is necessary for the health and structure of the interstitial cells of Cajal. These cells act as the pacemakers of the gut, controlling the electrical signals that tell the intestinal muscles to contract during the migrating motor complex9.
Because the bacterial toxin and the human protein look alike, the immune system becomes confused. It creates anti-vinculin antibodies that accidentally attack the body’s own pacemaker cells9. This autoimmune reaction damages the nerves and stops the migrating motor complex from functioning correctly. A reduction in the density of the interstitial cells of Cajal correlates directly with a higher risk of bacterial overgrowth10. This mechanism explains why some people develop chronic bacterial overgrowth months or even years after a single case of food poisoning11.

Prokinetic medications for relapse prevention

Preventing a relapse in people with nerve damage requires long-term mechanical support for the digestive tract. Because the natural pacemaker cells are damaged, these individuals use medications or supplements called prokinetics. Prokinetics artificially stimulate the cleaning wave to compensate for the damaged nerves and push bacteria into the colon5.
Prokinetics are different from laxatives. Laxatives draw water into the colon to induce a bowel movement. Prokinetics work specifically on the small intestine to trigger the migrating motor complex during fasting windows13. They are typically taken at bedtime or between meals to keep the small intestine clear.

Prokinetic Agent Type Mechanism of Action Common Use in Prevention
Low-dose naltrexone Pharmaceutical Blocks opioid receptors briefly, leading to an increase in endorphins that stimulates motility and reduces inflammation. Used at 1.5 to 4.5 mg at bedtime for patients with autoimmune nerve damage.
Low-dose erythromycin Pharmaceutical Acts as an agonist for motilin receptors, directly stimulating Phase III of the migrating motor complex. Used at 50 mg at bedtime to trigger overnight cleaning waves.
Prucalopride Pharmaceutical Activates 5-HT4 serotonin receptors to promote intestinal muscle contractions. Used at 0.5 to 1 mg at bedtime for slow-transit conditions.
Ginger root Natural supplement Stimulates gastric emptying and small bowel transit through natural chemical compounds. Used alone or in herbal blends at 1,000 mg at bedtime.

Relying on prokinetics is a common prevention strategy for individuals who test positive for anti-vinculin antibodies5. Without this daily mechanical support, the bacteria repopulate the stagnant small intestine within a few weeks of finishing antibiotic therapy5.

Meal spacing and the fasting window

Daily eating habits directly influence the migrating motor complex. Because the cleaning wave only happens when a person is fasting, frequent eating patterns interfere with the body’s ability to clear out bacteria.
Eating small meals throughout the day or grazing on snacks prevents the stomach from fully emptying. Every time food enters the stomach, the migrating motor complex halts its cleaning cycle to begin the digestion process7. To prevent a relapse, healthcare providers recommend spacing meals at least four to five hours apart. This schedule gives the body enough time to digest the food, empty the stomach, and run a complete 90-minute cleaning wave through the small intestine before the next meal arrives15.
An overnight fast of at least 12 hours provides an even longer window for the body to sweep bacteria into the colon7. Stopping food intake at least three hours before bedtime ensures the stomach is empty during sleep, which is when the migrating motor complex is most active7.

The vagus nerve and stress management

The vagus nerve connects the brain to the digestive tract and controls the speed of digestion. High stress levels shut down vagus nerve activity and halt the migrating motor complex7.
The body operates on two main nervous system modes: the sympathetic state (the fight-or-flight response) and the parasympathetic state (the rest-and-digest response). Chronic psychological or physical stress keeps the body in the sympathetic state. This diverts blood flow and energy away from the digestive organs and slows down the movement of food through the intestines7. Managing daily stress through deep breathing exercises, vagus nerve stimulation, and physical movement helps keep the nervous system in a parasympathetic state. This allows the digestive tract to maintain its normal rhythm and prevents the stagnation that leads to bacterial overgrowth7.

Systemic diseases and nerve dysfunction

Several chronic medical conditions damage the nerves and muscles of the entire body, including the digestive tract. People with these conditions have a much higher risk of relapse because their migrating motor complex is permanently impaired by their underlying disease.
Diabetes is a frequent underlying cause. Over time, high blood sugar levels cause systemic nerve damage, a condition known as diabetic autonomic neuropathy. When this nerve damage affects the enteric nervous system of the gut, it slows down the movement of food and bacteria4. The prevalence of bacterial overgrowth rises significantly in diabetic patients, particularly those who experience chronic diarrhea4.
Systemic sclerosis (scleroderma) heavily impacts digestive movement. This autoimmune condition causes the body to produce excess collagen, which creates thick fibrotic scar tissue. When this scar tissue forms in the walls of the small intestine, the intestinal muscles become rigid and lose their ability to contract effectively. This leads to severe stagnation, making bacterial overgrowth a constant and dangerous complication for people with this disease18.
Hypothyroidism also slows down the body’s systems. A lack of thyroid hormone reduces the overall metabolic speed of digestion and weakens muscle contractions in the gut. This sluggish movement gives bacteria more time to multiply before they are swept into the large intestine19.
Other systemic conditions associated with severe motility issues include Ehlers-Danlos syndrome, Parkinson’s disease, and Postural Orthostatic Tachycardia Syndrome (POTS). Parkinson’s disease delays gastric emptying, leaving food in the upper digestive tract for extended periods21. Connective tissue disorders like Ehlers-Danlos syndrome cause structural laxity in the digestive organs, while POTS creates an autonomic nervous system imbalance that disrupts normal bowel function22. Managing the primary disease is a necessary step to keep the gut moving and prevent the bacteria from returning.

Chemical barriers in the digestive tract

The body uses strong chemicals to kill bacteria before they can reach the small intestine. When the organs that produce these chemicals fail to make enough of them, bacteria survive the journey through the stomach and set up colonies further down the digestive tract.

Stomach acid and proton pump inhibitors

Gastric acid is the body’s first major defense against ingested bacteria. The high acidity of the stomach destroys most microbes that enter through the mouth on food and in saliva2. A lack of stomach acid, a condition known as hypochlorhydria, allows large numbers of bacteria to survive and pass into the small intestine2.
A common reason for low stomach acid is the long-term use of proton pump inhibitors. These medications treat acid reflux and heartburn by blocking the stomach’s ability to produce acid. While they relieve heartburn symptoms, they remove the primary chemical barrier that keeps bacteria in check. Studies show a direct connection between the continuous use of proton pump inhibitors and a higher risk of bacterial overgrowth recurrence25. The risk of overgrowth increases with the duration of the medication use, as each additional month of acid suppression allows more bacteria to migrate downward into the digestive tract26.
Aging also naturally reduces stomach acid production, making older adults highly susceptible to recurring overgrowths8. Additionally, chronic infection with Helicobacter pylori damages the stomach lining and reduces acid output29. For people prone to relapses, evaluating the need for antacid medications is an important prevention step. If stopping the medication is not possible, some individuals use supplements like betaine hydrochloride or apple cider vinegar to artificially increase stomach acid during meals5.

Pancreatic enzymes and digestion

Further down the digestive tract, the pancreas provides additional chemical defenses. The pancreas produces proteolytic digestive enzymes that break down proteins, carbohydrates, and fats into absorbable nutrients. These enzymes also have strong antibacterial properties that degrade bacterial cell walls and prevent microbes from multiplying in the small intestine2.
If the pancreas is damaged from conditions like chronic pancreatitis or cystic fibrosis, it cannot release enough enzymes. This condition is called exocrine pancreatic insufficiency31. Without enough enzymes, food remains undigested in the small intestine for too long. This undigested food ferments and becomes a direct food source for bacteria, fueling their rapid growth16. Between 30 and 40 percent of patients with chronic pancreatitis suffer from recurring bacterial overgrowth due to this lack of enzymes31. Supporting digestion with supplemental pancreatic enzymes is a strategy used to replace this missing chemical barrier and starve the bacteria16.

Bile acids and fat malabsorption

The liver produces bile, which is stored in the gallbladder and released into the small intestine to digest fats. Like stomach acid and pancreatic enzymes, bile is highly toxic to bacteria and limits their ability to grow2. Reduced bile production from liver disease, cirrhosis, or a removed gallbladder removes an important antimicrobial fluid from the small intestine, making a relapse highly likely21.
The relationship between bile and bacteria is reciprocal. When bacteria overgrow in the small intestine, they actively alter the bile acids. The bacteria deconjugate the bile, which means they chemically break the bile salts apart33. Deconjugated bile acids cannot dissolve dietary fats properly. This interference leads to fat malabsorption, causing oily, fatty stools known as steatorrhea30.
Fat malabsorption creates a cascade of nutritional problems. Without proper fat digestion, the body cannot absorb fat-soluble vitamins, leading to deficiencies in Vitamin A, Vitamin D, Vitamin E, and Vitamin K28. Furthermore, high levels of unconjugated bile acids irritate the intestinal lining and cause rapid fluid secretion, leading to severe diarrhea34. Using bitter herbs like dandelion or gentian to stimulate healthy bile flow helps restore this chemical barrier and prevent bacteria from breaking down the digestive fluids16.

Structural and anatomical roadblocks

The physical shape of the digestive tract determines how easily bacteria can be cleared. Any structural abnormality that creates a blockage, a stagnant pool of fluid, or a hiding place for bacteria will lead to a high rate of relapse.

The ileocecal valve

The ileocecal valve is a small muscular sphincter located between the end of the small intestine (the ileum) and the beginning of the large intestine (the cecum). Its primary job is to open to let waste pass into the colon, and then close tightly to prevent the waste and colon bacteria from washing back up into the small intestine2.
The large intestine naturally houses trillions of bacteria, while the small intestine is meant to house very few. If the ileocecal valve does not close properly, the pressure drops, and bacteria easily migrate backward into the small intestine2.
Low pressure in the ileocecal valve is a heavily documented risk factor for recurring bacterial overgrowth2. Some people have their ileocecal valve surgically removed due to colon cancer, Crohn’s disease, or inflammatory bowel disease. Without this physical barrier, bacteria freely backflow into the small intestine. This anatomical change is permanent, making lifelong management strategies necessary to prevent continuous relapses5.

Adhesions, strictures, and fistulae

Previous abdominal surgeries create a high risk for anatomical issues. Procedures like an appendectomy, gallbladder removal, or hysterectomy often leave behind scar tissue called adhesions. These internal scars act like tight bands that wrap around the outside of the intestines. They restrict the natural movement of the gut and create strictures, which are narrow pinch points in the intestinal tube5.
When the intestine is pinched or restricted by scar tissue, the migrating motor complex cannot sweep the bacteria past the blockage. The bacteria get stuck behind the stricture, pool in the stagnant fluid, and begin to multiply8. Inflammatory bowel diseases like Crohn’s disease also create internal strictures and fistulae (abnormal connections between different loops of the intestine) due to chronic inflammation21.
Fixing structural problems is difficult. In some cases, specialized physical therapy known as visceral manipulation is used to gently massage the abdomen and break up minor scar tissue to improve intestinal mobility5. Severe blockages or strictures often require corrective surgery to open the passageway2.

Blind loops and diverticulosis

Certain gastrointestinal surgeries alter the plumbing of the digestive tract and create “blind loops.” A blind loop is a bypassed section of the intestine where food and fluids no longer flow normally. Procedures like a Roux-en-Y gastric bypass or a Billroth II stomach resection redirect the flow of food, leaving a section of the small intestine isolated8. Because the natural current of the digestive tract does not wash through this blind loop, bacteria pool in the stagnant area and overgrow, shielded from gastric acid21.
Similarly, some people develop small intestinal diverticulosis. Diverticula are small, bulging pouches that form in the wall of the small intestine. Bacteria easily hide inside these pouches, evade the cleaning wave of the migrating motor complex, and cause continuous relapses4.

Structural Abnormality Physical Mechanism Impact on Relapse Prevention
Low ileocecal valve pressure The muscular door between the intestines stays partially open. Allows continuous backward flow of colon bacteria into the small intestine.
Surgical blind loops Bypassed sections of the intestine from gastric bypass surgery. Creates a stagnant area without fluid flow where bacteria pool and multiply.
Intestinal adhesions Scar tissue bands wrap around the intestines after surgery. Pinches the intestine, trapping bacteria and preventing the cleaning wave from working.
Small bowel diverticulosis Bulging pouches form in the intestinal wall. Provides hiding spots for bacteria to evade the migrating motor complex.
Loss of ileocecal valve Surgical removal of the valve due to cancer or disease. Permanently removes the barrier between the high-bacteria colon and the low-bacteria small intestine.

Immune system factors and the gut environment

The body relies on an active immune system and a balanced microbial environment to keep opportunistic bacteria from taking over. When the local immunity in the gut drops, or when the overall diversity of the gut bacteria is poor, the environment becomes highly susceptible to an overgrowth relapse.

Secretory IgA deficiency

Secretory IgA is the most abundant antibody in the human immune system, and it acts as the first line of defense inside the gut lining. Its main function is to bind to invading bacteria, toxins, and food antigens in the intestinal fluid to stop them from attaching to the walls of the small intestine2.
When the body produces enough secretory IgA, the antibodies neutralize the bacteria so they can be swept away by the migrating motor complex. Some individuals have a genetic condition called selective IgA deficiency31. Others experience a drop in their secretory IgA levels due to chronic stress, poor nutrition, physical exhaustion, or long-term inflammation37.
Without enough of these antibodies, bacteria easily attach to the intestinal walls, form protective colonies, and overgrow31. Recognizing an immune deficiency helps explain why a person might relapse repeatedly despite having normal gut movement and normal stomach acid. Conditions that suppress the systemic immune system, such as HIV or common variable immunodeficiency, carry a highly elevated risk of recurring bacterial overgrowth for this exact reason2.

Microbiome diversity and the dangers of restrictive diets

The bacteria that make up the human microbiome are constantly competing for space and nutrients. A healthy, highly diverse microbiome naturally suppresses the overgrowth of bad bacteria because the beneficial bacteria crowd them out and consume the available resources16.
Many people use restrictive eating plans, such as the low-FODMAP diet or the Specific Carbohydrate Diet, to manage the bloating and pain associated with bacterial overgrowth. These diets remove fermentable carbohydrates, which are the main food source for the overgrown bacteria. While removing these carbohydrates starves the problem bacteria and reduces gas production, it also starves the beneficial bacteria in the large intestine38.
Staying on a highly restrictive diet for too long severely reduces the overall diversity of the gut microbiome. Long-term adherence to a low-FODMAP diet leads to a reduction in the number of beneficial gut bacteria, such as Bifidobacterium, and reduces the production of short-chain fatty acids39. A depleted microbiome has a much weaker defense against opportunistic bacteria, making the gut highly vulnerable to a relapse as soon as normal foods are reintroduced.

Dietary strategies for prevention

To prevent a relapse, experts recommend using restrictive diets only for short periods during the initial treatment phase. Once the overgrowth is cleared, changing the dietary strategy is necessary.
Instead of permanent restriction, practitioners often recommend a low-fermentation diet for maintenance. The low-fermentation diet is less restrictive than a low-FODMAP diet. It limits the most problematic, highly fermentable foods, such as artificial sweeteners, high-fructose corn syrup, and excessive dairy, but it allows for a wider variety of carbohydrates22. This approach prevents the rapid fermentation that causes bloating while still providing enough fiber to sustain a healthy microbiome41.
Slowly reintroducing fermentable fibers is necessary to feed the good bacteria and rebuild a resilient, diverse microbiome that can naturally resist future overgrowths7. A patient might introduce one new fermentable food every few days, starting with small portions of foods like lentils, garlic, or green banana flour16. By combining a diverse diet with proper meal spacing, prokinetic support, and management of any underlying diseases, the digestive tract regains its natural defenses, and the cycle of relapse is broken.

Works Cited & Scientific References 42
  1. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge - PMC
  2. Small Intestinal Bacterial Overgrowth - StatPearls - NCBI Bookshelf - NIH
  3. DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY - PMC
  4. Unraveling the Complexities of Small Intestinal Bacterial Overgrowth - PMC - NIH
  5. On The Mark Health And Wellness | Causes Of SIBO Recurrences in New York
  6. Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling - PubMed
  7. SIBO Treatment: How to Treat SIBO and Prevent Recurrence - Parsley Health
  8. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance - PMC
  9. Could Food Poisoning Be The Reason For Your Chronic Digestive Symptoms?
  10. Association between interstitial cells of Cajal and anti-vinculin antibody in human stomach
  11. What's the Best Functional Medicine Approach to SIBO Success? - Coho Health
  12. Prokinetics for SIBO - IBS Clinics
  13. Case Study: Recalcitrant Hydrogen and Methane SIBO in the Setting of Post-Infectious IBS
  14. Low-Dose Naltrexone: Mechanism and Applications - Lamkin Clinic
  15. Breaking Down SIBO: Your Complete Guide to Beating It and Restoring Gut Harmony
  16. Why Does SIBO Relapse and How to Prevent It - Bella Lindemann
  17. Vagus Nerve & SIBO: How Stimulation Improves Gut Health, Sleep & Mood
  18. Eradication of Small Intestinal Bacterial Overgrowth in Systemic Sclerosis: Current Treatment and Perspectives—A Narrative Review - PMC
  19. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
  20. The Link Between SIBO and Your Thyroid | Paloma Health
  21. Aetiology, diagnosis and management of small intestinal bacterial overgrowth - PMC - NIH
  22. IBS: It's Not In Your Head—Advances In Diagnosing And Treating, Bloating And Tummy Troubles - Mark Hyman, MD
  23. Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment - PMC
  24. IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions
  25. Epidemiology of small intestinal bacterial overgrowth - PMC - NIH
  26. The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis - PMC
  27. Small intestinal bacterial overgrowth recurrence after antibiotic therapy - PubMed
  28. How to Recognize and Treat Small Intestinal Bacterial Overgrowth? - PMC
  29. SIBO Studies: 2023 - SIBOINFO
  30. Small Intestinal Bacterial Overgrowth: A Comprehensive Review - PMC - NIH
  31. Small intestinal bacterial overgrowth syndrome - PMC - NIH
  32. Small Intestine Bacterial Overgrowth: Common but Overlooked Cause of IBS | NDNR
  33. Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review - PMC
  34. Bile Acid and Gut Microbiota in Irritable Bowel Syndrome - Journal of Neurogastroenterology and Motility
  35. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods - PMC
  36. Small intestinal bacterial overgrowth and intestinal methanogen overgrowth in gastrointestinal malignancies - PMC
  37. Secretory IgA (sIgA) in Stool: What High and Low Results Mean on Your GI-MAP
  38. What Is SIBO? Symptoms, Testing, and Treatment Explained - Seed
  39. Dietary and Lifestyle Factors Associated with Small Intestinal Bacterial Overgrowth (SIBO) - Type of the Paper (Article - UMK
  40. Treating & Managing SIBO, IMO, and ISO Effectively - Trio-Smart
  41. Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review
  42. (PDF) Small Intestinal Bacterial Overgrowth - ResearchGate